XML 37 R27.htm IDEA: XBRL DOCUMENT

Impairment Loss	9 Months Ended
Sep. 30, 2023
Impairment Loss [Abstract]
IMPAIRMENT LOSS	21. IMPAIRMENT LOSS The Company recorded $3,872 and $0.23 million of impairment loss in nine months ended 2023 and 2022 relating to the short - term investment mainly due to Future Private Equity Fund Management (Hainan) Co., Ltd. invested $1.85 million (RMB13,000,000) to entrust Shanghai Yuli Enterprise Management Consulting Firm to invest in various types of investment portfolios. The Company may still suffer significant impairment loss or downward adjustments of our investments in the future, due to the potential worsening global economic conditions, high interest rate and the volatility in the continuing low market price of shares that caused the Company to recognize a fair-value loss in nine months ended September 30, 2023 and 2022. According to the market value, the Company’s balance of the short - term investment was $0.95 million and $0.98 million on September 30, 2023 and December 31, 2022.

Impairment Loss

9 Months Ended

Sep. 30, 2023

21. IMPAIRMENT LOSS

The Company recorded $3,872 and $0.23 million of impairment loss in nine months ended 2023 and 2022 relating to the short - term investment mainly due to Future Private Equity Fund Management (Hainan) Co., Ltd. invested $1.85 million (RMB13,000,000) to entrust Shanghai Yuli Enterprise Management Consulting Firm to invest in various types of investment portfolios. The Company may still suffer significant impairment loss or downward adjustments of our investments in the future, due to the potential worsening global economic conditions, high interest rate and the volatility in the continuing low market price of shares that caused the Company to recognize a fair-value loss in nine months ended September 30, 2023 and 2022. According to the market value, the Company’s balance of the short - term investment was $0.95 million and $0.98 million on September 30, 2023 and December 31, 2022.